NCT02614742 - SFX-01 After Subarachnoid Haemorrhage | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

September 30, 2019

Study Completion Date

November 30, 2019

Conditions

Subarachnoid Hemorrhage, Spontaneous

Interventions

DRUG

SFX-01

An intervention releasing sulforaphane.

DRUG

Placebo

Placebo otherwise identical to Active product

Trial Locations (3)

Southampton General Hospital, Southampton

Western General Hospital, Edinburgh

The Royal London Hospital, London